FDA Inspection 1026803 — Lyne Laboratories, Inc.
The FDA completed an inspection of Lyne Laboratories, Inc. on Sep 7, 2017 in Brockton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brockton, MA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)